Immunitybio Inc (IBRX)
$8.29 -5.15% Close Oct 30, 2026 Live
Immunitybio stock today
Immunitybio closed at $8.29 on October 30, 2026, down 5.15% on the day. Over the past year it returned +251.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $8.68 billion.
$5.00$10.00
NovJan 2026MarMayJulSep
| Period | IBRX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -12.2% | -0.9% |
| 3 months | +11.3% | +2.1% |
| Year to date | +318.7% | +11.7% |
| 1 year | +251.3% | +12.4% |
| 3 years | +169.2% | +88.5% |
| 5 years | +5.9% | +76.0% |
Key statistics
- Market value
- $8.68B
- Price / sales
- 52.4
- 52-week range
- $1.98 to $11.55
- Next report
- Nov 3, 2026 (estimated)
About Immunitybio
Immunitybio develops immunotherapy treatments for cancer and infectious diseases.
Sector: Health Care
More on Immunitybio
- Financials: revenue, earnings and segmentsRevenue +668% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $1,389 today
No forecast, no recommendation. This page describes Immunitybio Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.